| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $-0.03 (Beat by $0.03) |
| EPS GAAP Actual | $-0.03 (Beat by $0.03) |
| Revenue Actual | $0.0147963B |
| Revenue Surprise | Beat by $14.7963M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.21 |
| EPS GAAP Estimate | $-0.21 |
| Revenue Estimate | $0.0139B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.85 | 1.82 | 0.85 | 0.85 | 1 |
| Dec 2025 | 0.32 | 4.84 | 0.32 | 0.32 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.03 | -0.07 | 0.0147963B | 14.29% | 1.5M |
| FQ2 2025 (Jun 2025) | -0.13 | -0.3 | 0.0140875B | 18.73% | -2.41M |
| FQ1 2025 (Mar 2025) | -0.21 | -0.22 | 0.0121697B | -25.2% | 0.57M |
| FQ4 2024 (Dec 2024) | -0.18 | -0.1 | 0.0123176B | 2.4% | -0.38M |
| FQ3 2024 (Sep 2024) | -0.8 | -0.86 | 0.0126824B | 19.7% | -0.82M |
| FQ2 2024 (Jun 2024) | -0.0835 | -1.42609 | 0.0114491B | -96194.91% | -10.6M |
| FQ1 2024 (Mar 2024) | -0.0177 | -0.0177 | 0.0152359B | 35.08% | 15.24M |
| FQ4 2023 (Dec 2023) | -0.58 | -0.58 | 0.0120222B | 7.35% | 12.02M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.21
Consensus Revenue Estimates
0.0139B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.74 | -- | 0.74 | 0.74 | 1 |
| FQ3 2026 (Sep 2026) | 0.24 | 112.5 | 0.24 | 0.24 | 1 |
| FQ2 2026 (Jun 2026) | 0.08 | 262.5 | 0.08 | 0.08 | 1 |
| FQ1 2026 (Mar 2026) | -0.21 | 0 | -0.21 | -0.21 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ3 2026 (Sep 2026) | 0.02B | 8.66 | 0.02B | 0.02B | 1 |
| FQ2 2026 (Jun 2026) | 0.02B | 6.08 | 0.02B | 0.02B | 1 |
| FQ1 2026 (Mar 2026) | 0.01B | 12.45 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.04 | -0.03 | -0.07 | 233.33% |
| FQ2 2025 (Jun 2025) | 0.17 | -0.13 | -0.3 | 230.77% |
| FQ1 2025 (Mar 2025) | 0.01 | -0.21 | -0.22 | 104.76% |
| FQ4 2024 (Dec 2024) | -0.08 | -0.18 | -0.1 | 55.56% |
| FQ3 2024 (Sep 2024) | 0.06 | -0.8 | -0.86 | 107.5% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.0835 | -1.42609 | 1707.89% |
| FQ1 2024 (Mar 2024) | -0.0177 | -0.0177 | 100% | |
| FQ4 2023 (Dec 2023) | -0.58 | -0.58 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.01B | $0.01B | $1.5M | 10.11% |
| FQ2 2025 (Jun 2025) | $0.02B | $0.01B | $-2.41M | -17.13% |
| FQ1 2025 (Mar 2025) | $0.01B | $0.01B | $0.57M | 4.68% |
| FQ4 2024 (Dec 2024) | $0.01B | $0.01B | $-0.38M | -3.1% |
| FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $-0.82M | -6.45% |
| FQ2 2024 (Jun 2024) | $0.02B | $0.01B | $-10.6M | -92.59% |
| FQ1 2024 (Mar 2024) | $0B | $0.02B | $15.24M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.01B | $12.02M | 100% |